Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness.
about
Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutationsPaired measurements of paraoxonase 1 and serum amyloid A as useful disease markersSAA1 polymorphisms are associated with variation in antiangiogenic and tumor-suppressive activities in nasopharyngeal carcinomaA link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4Detection of novel truncated forms of human serum amyloid A protein in human plasma.Proteomic analysis of blood level of proteins before and after operation in patients with esophageal squamous cell carcinoma at high-incidence area in Henan Province.Serum amyloid A: a novel biomarker for endometrial cancer.Easy-to-Fabricate and High-Sensitivity LSPR Type Specific Protein Detection Sensor Using AAO Nano-Pore Size Control.A combined biomarker pattern improves the discrimination of lung cancer.Investigating diversity in human plasma proteinsA constitutively activated form of the p110beta isoform of PI3-kinase induces prostatic intraepithelial neoplasia in mice.Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinomaPreliminary characterizations of a serum biomarker for sarcoidosis by comparative proteomic approach with tandem-mass spectrometry in ethnic Han Chinese patients.Investigation of the solubility and the potentials for purification of serum amyloid A (SAA) from equine acute phase serum--a pilot studySome acute phase reactants and cholesterol levels in serum of patient with Crimean-Congo haemorrhagic fever.Comparison of serum amyloid A protein and C-reactive protein levels as inflammatory markers in periodontitis.Relative serum amyloid A (SAA) values: the influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritisProteasome β5i Subunit Deficiency Affects Opsonin Synthesis and Aggravates Pneumococcal PneumoniaSerum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis.Clinicopathologic significance of expression of nuclear factor-κB RelA and its target gene products in gastric cancer patientsAmyloidosis and the lung.Identifying viral infections in vaccinated Chronic Obstructive Pulmonary Disease (COPD) patients using clinical features and inflammatory markers.Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients.Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patientsSerum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer.Decrease of circulating SAA is correlated with reduction of abdominal SAA secretion during weight loss.Serum amyloid A1: Structure, function and gene polymorphism.Postoperative changes in high mobility group box 1 levels after colorectal cancer surgery.Expression of C-Reactive Protein and Serum Amyloid A in Early to Late Manifestations of Lyme Disease.The correlation between the cardio-ankle vascular index (CAVI) and serum amyloid A in asymptomatic Japanese subjects.Pretreatment Serum Amyloid A and C - Reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective Study.Comparison of serum amyloid A and C-reactive protein as diagnostic markers of systemic inflammation in dogs.N-terminal hydrophobic amino acids of activating transcription factor 5 (ATF5) protein confer interleukin 1β (IL-1β)-induced stabilization.Fenofibrate inhibits reactive amyloidosis in mice.Plasma proteomics analysis of tamoxifen resistance in breast cancer.Adipogenesis and lipid production in adipocytes subjected to sustained tensile deformations and elevated glucose concentration: a living cell-scale model system of diabesity.Localization of injected anti-serum amyloid A antibody to the lesions in murine reactive amyloidosis.Evaluation of the diagnostic accuracy of plasma markers for early diagnosis in patients suspected for acute appendicitis.Ageing: a risk factor for amyloid A amyloidosis in rheumatoid arthritis.Pioglitazone improves the cardiovascular profile in patients with uncomplicated systemic lupus erythematosus: a double-blind randomized clinical trial.
P2860
Q24300638-B37F9F81-74F4-4669-A76C-AB607BD2CBD8Q27006749-255492D8-5D58-4F78-A3D4-CBCC93DA72CDQ28235586-E22389A1-158F-41FC-805D-F3ACD8277534Q28306743-9E01C325-BC56-47C1-89EA-07D14BB978ADQ31133257-EC3F3327-7EF7-4D6C-B31B-38177886E7FEQ33207901-7E0EFE9F-47FC-4BCF-BA7E-340F6135DE2AQ33643221-44403DC6-C5EC-4E5B-A453-9DD70382085BQ33656220-05D5CB43-D1A1-490C-9AFA-95288F974343Q33724593-CCEF770F-CC97-4454-8099-7FA4618B9F85Q33905685-F5ADF780-1253-4169-942F-C08C612343D1Q33934457-A76F5B68-6F28-4A81-AACD-6CEE63D54A2DQ34392042-7651B1D6-5DED-489F-8EAD-F088EB1AA3B3Q34582445-66F3A155-2A4B-4EB6-80B7-F5AE6D2A9D3EQ34670833-071710EB-0A40-45FE-BBF2-A8EC3F9A6546Q35099718-AEFAF93F-C428-4A48-B107-1C5353EBA965Q35123578-751E4324-3389-4A85-80F3-1E8584F3F778Q35550047-3E51A057-0803-4C6A-A247-803399A7DBF7Q35995706-3E3FBD5E-2CC7-465A-B5BE-59F8E18F3C56Q36178078-F43D14EC-7C29-4BF8-8774-EFCFBC2E644EQ36233861-B7A22892-5A59-4502-A8D5-90085D4385B0Q36692876-7FE795CB-1CC6-42BD-8BC9-9CC60A296FFEQ37087772-B6686C61-08A2-4DD9-8FBE-8D14FE78AA58Q37220965-2BDB240E-19FF-44B9-B982-11804026937AQ37280710-122522D9-82A6-43E6-B064-A937BF010F4AQ37287461-7E355322-BC27-4C97-BC75-C2ADBA1D6B67Q37669535-3BD87603-40C5-48B7-B44A-19B3EC4A7B5AQ38761950-F93D5478-EF45-4B9E-8C8B-4E134FB8E73AQ39196658-C1765CB3-AB6E-468B-8D9D-1FF0305668CDQ39431370-D323F734-6DE4-40EC-A074-1FE98042B294Q39710689-C0EF162C-CC30-49A1-8BBE-F89608333863Q40123094-1D6F59C6-6AC5-4ACC-86BF-9AB132206EB8Q41877450-B2120BB0-A90B-4F1F-A358-3CA509A5C1B6Q41954745-D8E95968-CE04-401B-B933-44F9C152F4CAQ44062265-CE5C8B48-816C-4D40-AC82-E8621EA59763Q44493749-FED57E81-1823-43D8-B1FE-AB272D97960AQ47563057-1C14D15E-EF88-42F8-A43A-460BFD7A0246Q47702934-3654E350-11E1-479A-8A94-A1E64123A45EQ47998123-696A97AC-3337-442D-8525-639C0C9F86EFQ51164648-56B5992C-7C8D-4D26-9AB8-0C056E9B10F4Q51366906-0FF0833D-1AA2-4711-9A1A-CE09740DFCBD
P2860
Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Serum amyloid A (SAA): a conci ...... thods and clinical usefulness.
@ast
Serum amyloid A (SAA): a conci ...... thods and clinical usefulness.
@en
type
label
Serum amyloid A (SAA): a conci ...... thods and clinical usefulness.
@ast
Serum amyloid A (SAA): a conci ...... thods and clinical usefulness.
@en
prefLabel
Serum amyloid A (SAA): a conci ...... thods and clinical usefulness.
@ast
Serum amyloid A (SAA): a conci ...... thods and clinical usefulness.
@en
P356
P1476
Serum amyloid A (SAA): a conci ...... thods and clinical usefulness.
@en
P2093
P304
P356
10.1515/CCLM.1999.063
P577
1999-04-01T00:00:00Z